Belgian Regulator Penalizes Over-the-Counter Drug Distributors in Latest European Examination of Pharmaceutical Practices

The Belgian antitrust regulator has penalized several major distributors of over-the-counter medications. The action marks the most recent instance of a European nation examining pharmaceutical industry practices. Specifically, the Belgian regulator scrutinized the business activities of several of the largest suppliers of non-prescription drugs. This investigation contributes to a broader trend of European countries increasing their oversight of the pharmaceutical sector. The regulator’s sanctions suggest they found practices worthy of penalty, and the action indicates a growing concern over competition and pricing within the over-the-counter medicine market.

Newsflash | Powered by GeneOnline AI
Date: April 25, 2025

Author

Mark Chiang